Literature DB >> 1931011

Detection of loss of heterozygosity in tumor DNA samples by PCR.

G R Merlo1, C S Cropp, R Callahan, T Takahashi.   

Abstract

We demonstrate that PCR amplification of human genomic DNA can be used for the detection of loss of heterozygosity (LOH) in tumor samples. A 250-bp fragment containing codon 72 of the human p53 gene was amplified, ThaI digested and electrophoresed. Tumor LOH is detectable both by ethidium bromide staining and autoradiography, despite 25% contamination with normal DNA. This technique provides a fast and reproducible alternative to conventional Southern blotting and has minimal sample requirements.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931011

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  8 in total

1.  Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization.

Authors:  Dimitrios Koutsimpelas; Uwe Felmeden; Wolf J Mann; Jürgen Brieger
Journal:  J Neurooncol       Date:  2010-09-26       Impact factor: 4.130

2.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

Authors:  N Konishi; Y Hiasa; H Matsuda; M Tao; T Tsuzuki; I Hayashi; Y Kitahori; T Shiraishi; R Yatani; J Shimazaki
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Detection of P53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications.

Authors:  M A Kuczyk; J Serth; C Hervatin; H Arndt; L Derendorf; W F Thon; U Jonas
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

5.  Low frequency and late occurrence of p53 and dcc aberrations in colorectal tumours.

Authors:  N J Froggatt; S H Leveson; R C Garner
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

Authors:  S M Phillips; C M Barton; S J Lee; D G Morton; D M Wallace; N R Lemoine; J P Neoptolemos
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

7.  p53 mutations occur in clinical, but not latent, human prostate carcinoma.

Authors:  N Konishi; Y Hiasa; I Hayashi; H Matsuda; T Tsuzuki; T Ming; Y Kitahori; T Shiraishi; R Yatani; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1995-01

8.  Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.

Authors:  W J Wu; Y Kakehi; T Habuchi; H Kinoshita; O Ogawa; T Terachi; C H Huang; C P Chiang; O Yoshida
Journal:  Jpn J Cancer Res       Date:  1995-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.